A novel dynamic risk score to predict venous thromboembolism (VTE) recurrences after 3 months of anticoagulation in patients with incident VTE and without active cancer

被引：0
|
作者：
Cohen, A. [1 ]
Choudhuri, S. [2 ]
Khan, I [3 ]
Pollock, K. [4 ]
Bober-Irizar, M. [5 ]
Galias, Z. [6 ]
Irizar, A. [5 ]
Bober, M. [7 ]
机构：
[1] Guys & St Thomas NHS Trust Hosp, London, England
[2] Northern Care Alliance NHS Fdn Trust, Manchester, England
[3] Pfizer Ltd, Tadworth, England
[4] Bristol Myers Squibb, London, England
[5] ForecomAI, London, England
[6] AGH Univ Sci & Technol, Krakow, Poland
[7] Univ Surrey, Fac Hlth & Med Sci, Guildford, England
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A novel dynamic risk score to predict venous thromboembolism (VTE) recurrences after 3 months of anticoagulation in patients with incident VTE and without active cancer
    Cohen, A.
    Choudhuri, S.
    Khan, I
    Pollock, K.
    Bober-Irizar, M.
    Galias, Z.
    Irizar, A.
    Bober, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [2] A novel dynamic risk score to predict Clinically Significant Bleeding (CSB) after 3 months of anticoagulation in patients with incident Venous ThromboEmbolism (VTE) and without active cancer
    Cohen, A.
    Choudhuri, S.
    Khan, I
    Pollock, K.
    Bober-Irizar, M.
    Galias, Z.
    Irizar, A.
    Bober, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [3] Risk factors for venous thromboembolism (VTE) recurrences in Thai patients without cancer
    Satpanich, Panchalee
    Rojnuckarin, Ponlapat
    HEMATOLOGY, 2019, 24 (01) : 159 - 165
  • [4] Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
    de Winter, Maria A.
    Buller, Harry R.
    Carrier, Marc
    Cohen, Alexander T.
    Hansen, John-Bjarne
    Kaasjager, Karin A. H.
    Kakkar, Ajay K.
    Middeldorp, Saskia
    Raskob, Gary E.
    Sorensen, Henrik T.
    Visseren, Frank L. J.
    Wells, Philip S.
    Dorresteijn, Jannick A. N.
    Nijkeuter, Mathilde
    VTE PREDICT study Grp
    EUROPEAN HEART JOURNAL, 2023, 44 (14) : 1231 - 1244
  • [5] A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score
    Angelini, Dana E.
    Greene, M. Todd
    Wietzke, Julie N.
    Flanders, Scott A.
    Sood, Suman L.
    BLOOD, 2016, 128 (22)
  • [6] Anticoagulation and Bleeding Risk in Elderly Patients with venous Thromboembolism (VTE)
    Thomas, H. -P.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S41 - S41
  • [7] Bleeding Risk in Thrombocytopenic Cancer Patients with Venous Thromboembolism (VTE) Receiving Anticoagulation
    Pemmaraju, Naresh
    Kroll, Michael H.
    Afshar-Kharghan, Vahid
    Oo, Thein H.
    BLOOD, 2012, 120 (21)
  • [8] Factors That Predict The Risk Of Recurrent Venous Thromboembolism (VTE) In Patients With VTE And Factor V Leiden (FVL)
    Couturaud, F.
    Noel-Savina, E.
    Paleiron, N.
    Quere, G.
    Mottier, D.
    Leroyer, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [9] Evaluation of VTE-PREDICT Risk Score in Patients Receiving Low-Dose DOACs for Venous Thromboembolism (VTE) Secondary Prophylaxis
    Lagana, Alessandro
    Assanto, Giovanni Manfredi
    Passucci, Mauro
    Santoro, Cristina
    Chistolini, Antonio
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [10] Competing risks analysis of recurrent venous thromboembolism ( VTE) and bleeding on anticoagulation in patients with cancer-associated VTE
    Simon, David
    Le Mao, Raphael
    Raj, Leela
    Espinasse, Benjamin
    De Moreuil, Claire
    Tromeur, Cecile
    Guegan, Marie
    Poulhazan, Elise
    Le Moigne, Emmanuelle
    Lacut, Karine
    Leroyer, Christophe
    Mahe, Isabelle
    Nowak, Emmanuel
    Couturaud, Francis
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345